...
首页> 外文期刊>Drug Design, Development and Therapy >Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection
【24h】

Preparation and in vitro/in vivo evaluation of PLGA microspheres containing norquetiapine for long-acting injection

机译:含长效注射用norquetiapine的PLGA微球的制备及体外/体内评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Norquetiapine ( N -desalkyl quetiapine, NQ) is an active metabolite of quetiapine with stable pharmacokinetic and pharmacological properties. However, its short half-life is a drawback for clinical applications, and long-acting formulations are required. Purpose: The objectives of this study were to prepare improved entrapment efficiency NQ freebase microspheres by the solvent evaporation method with poly(d,l-lactic-co-glycolic acid) (PLGA) as a release modulator and to evaluate their physicochemical and in vitro/in vivo release properties. Methods: NQ freebase PLGA (1:5 w/w) formulations were prepared by the oil-in-water (o/w) emulsion–solvent evaporation method. A solution of the drug and PLGA in 9:1 v/v dichloromethane:ethanol was mixed with 0.2% polyvinyl alcohol and homogenized at 2,800 rpm. The emulsion was stirred for 3 h to dilute and evaporate the solvent. After that, the resulting product was freeze-dried. Drug-loading capacity was measured by the validated RP-HPLC method. The surface morphology of the microspheres was observed by scanning electron microscopy (SEM), and the physicochemical properties were evaluated by differential scanning calorimetry, powder X-ray diffraction, and Fourier-transform infrared spectroscopy particle size distribution. The in vitro dissolution test was performed using a rotary shaking bath at 37°C, with constant shaking at 50 rpm in sink condition. Results: The NQ freebase microspheres prepared by o/w emulsion-solvent evaporation showed over 30 % efficiency. NQ was confirmed to be amorphous in the microspheres by powder X-ray diffraction and differential scanning calorimetry. Special chemical interaction in the microspheres was not observed by FT-IR. The in vitro dissolution test demonstrated that the prepared microspheres' release properties were maintained for more than 20 days. The in vivo test is also confirmed that the particles' long acting of the particle were maintained. Therefore, good in vitro–in vivo correlation was established. Conclusion: In this study, NQ freebase-PLGA microspheres showed potential for the treatment of schizophrenia for long-periods.
机译:背景:Norquetiapine(N-去烷基喹硫平,NQ)是喹硫平的活性代谢产物,具有稳定的药代动力学和药理学性质。但是,其半衰期短对于临床应用是一个缺点,需要长效制剂。目的:本研究的目的是通过以聚(d,l-乳酸-乙醇酸)(PLGA)为释放调节剂的溶剂蒸发法制备改善包封效率的NQ游离碱微球,并评估其理化和体外作用/体内释放特性。方法:NQ游离碱PLGA(1:5 w / w)制剂通过水包油(o / w)乳液-溶剂蒸发法制备。将药物和PLGA在9:1 v / v二氯甲烷:乙醇中的溶液与0.2%聚乙烯醇混合,并以2,800 rpm均化。将乳液搅拌3小时以稀释并蒸发溶剂。之后,将所得产物冷冻干燥。通过验证的RP-HPLC方法测量载药量。通过扫描电子显微镜(SEM)观察微球的表面形态,并通过差示扫描量热法,粉末X射线衍射和傅里叶变换红外光谱粒度分布评价理化性质。体外溶出度试验是在37°C的旋转摇浴中进行的,在水槽条件下以50 rpm的速度恒定摇动。结果:通过o / w乳液-溶剂蒸发制备的NQ游离碱微球显示出超过30%的效率。通过粉末X射线衍射和差示扫描量热法证实NQ在微球中为非晶态。 FT-IR未观察到微球中的特殊化学相互作用。体外溶出试验表明,制备的微球的释放性能保持了20天以上。体内试验还证实了维持了颗粒的长效作用。因此,建立了良好的体外-体内相关性。结论:在这项研究中,NQ游离碱-PLGA微球在长期治疗精神分裂症方面显示出潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号